Masimo Corporation (NASDAQ:MASI)‘s stock had its “buy” rating reissued by investment analysts at Stifel Nicolaus in a report issued on Friday. They currently have a $108.00 price target on the medical equipment provider’s stock. Stifel Nicolaus’ target price would indicate a potential upside of 25.58% from the stock’s previous close.
A number of other research analysts have also recently weighed in on the stock. Roth Capital lifted their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. Zacks Investment Research upgraded shares of Masimo Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. BidaskClub upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Finally, BTIG Research upgraded shares of Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Monday, August 14th. One analyst has rated the stock with a sell rating, three have given a hold rating and five have assigned a buy rating to the stock. Masimo Corporation currently has a consensus rating of “Hold” and an average target price of $97.17.
Shares of Masimo Corporation (NASDAQ MASI) traded down $1.93 on Friday, hitting $86.00. 261,418 shares of the company’s stock were exchanged, compared to its average volume of 384,306. The firm has a market cap of $4.37 billion, a price-to-earnings ratio of 32.37 and a beta of 0.75.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.17. The firm had revenue of $193.69 million during the quarter, compared to analysts’ expectations of $189.01 million. Masimo Corporation had a net margin of 45.83% and a return on equity of 22.17%. The business’s quarterly revenue was up 15.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.52 earnings per share. research analysts expect that Masimo Corporation will post 2.96 EPS for the current fiscal year.
In other Masimo Corporation news, EVP Yongsam Lee sold 5,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The shares were sold at an average price of $89.89, for a total transaction of $449,450.00. Following the completion of the transaction, the executive vice president now owns 74,000 shares in the company, valued at approximately $6,651,860. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Sanford Fitch sold 11,000 shares of the business’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $87.25, for a total transaction of $959,750.00. Following the transaction, the director now owns 72,249 shares of the company’s stock, valued at approximately $6,303,725.25. The disclosure for this sale can be found here. Insiders have sold a total of 26,000 shares of company stock valued at $2,309,200 in the last quarter. 16.60% of the stock is currently owned by company insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the business. Fortaleza Asset Management Inc. acquired a new position in Masimo Corporation during the 2nd quarter worth approximately $106,000. Dubuque Bank & Trust Co. grew its holdings in Masimo Corporation by 3.4% during the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock worth $170,000 after acquiring an additional 61 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Masimo Corporation by 13.2% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,018 shares of the medical equipment provider’s stock worth $184,000 after buying an additional 236 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Masimo Corporation during the 2nd quarter worth approximately $203,000. Finally, Advisor Group Inc. lifted its position in shares of Masimo Corporation by 38.4% during the 2nd quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock worth $216,000 after buying an additional 655 shares during the last quarter. Institutional investors own 82.96% of the company’s stock.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.